Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

2.

Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF study.

Milo-Cotter O, Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Edwards C, Weatherley BD, Greenberg B, Filippatos G, Unemori E, Teichman SL, Cotter G.

Cardiology. 2010;117(3):190-6. doi: 10.1159/000321416. Epub 2010 Nov 17.

PMID:
21088400
3.

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC; PROTECT Investigators and Committees.

N Engl J Med. 2010 Oct 7;363(15):1419-28. doi: 10.1056/NEJMoa0912613.

4.

Acute heart failure clinical drug development: from planning to proof of activity to phase III.

Cotter G, Voors AA, Weatherley BD, Pang PS, Teerlink JR, Filippatos G, Ponikowski P, Milo-Cotter O, Dittrich H, Teichman SL, Adams KF, Gheorghiade M, Metra M.

Cardiology. 2010;116(4):292-301. doi: 10.1159/000318048. Epub 2010 Sep 28. Review.

PMID:
20881385
5.

Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function.

Ponikowski P, Mitrovic V, O'Connor CM, Dittrich H, Cotter G, Massie BM, Givertz MM, Chen E, Murray M, Weatherley BD, Fujita KP, Metra M.

Eur J Heart Fail. 2010 Nov;12(11):1238-46. doi: 10.1093/eurjhf/hfq137. Epub 2010 Sep 7.

6.

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.

Metra M, Teerlink JR, Felker GM, Greenberg BH, Filippatos G, Ponikowski P, Teichman SL, Unemori E, Voors AA, Weatherley BD, Cotter G.

Eur J Heart Fail. 2010 Oct;12(10):1130-9. doi: 10.1093/eurjhf/hfq132. Epub 2010 Aug 22.

7.

A randomized controlled trial of the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness.

Shemesh E, Annunziato RA, Weatherley BD, Cotter G, Feaganes JR, Santra M, Yehuda R, Rubinstein D.

J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. Epub 2010 Apr 6.

PMID:
20441725
8.

The management of acute heart failure.

Milo-Cotter O, Bettari L, Kleijn L, Bugatti S, Lombardi C, Rund M, Metra M, Voors AA, Cotter G, Kaluski E, Weatherley BD.

Panminerva Med. 2010 Mar;52(1):53-66. Review.

PMID:
20228726
9.

Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.

Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie BM, O'Connor CM, Ponikowski P, Teerlink JR, Voors AA, Cotter G.

Eur J Heart Fail. 2010 May;12(5):499-507. doi: 10.1093/eurjhf/hfq021. Epub 2010 Mar 12.

10.

Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.

Weatherley BD, Cotter G, Dittrich HC, DeLucca P, Mansoor GA, Bloomfield DM, Ponikowski P, O'Connor CM, Metra M, Massie BM; PROTECT Steering Committee, Investigators, and Coordinators.

J Card Fail. 2010 Jan;16(1):25-35. doi: 10.1016/j.cardfail.2009.10.025. Epub 2009 Dec 11.

PMID:
20123315
11.

Patterns of leukocyte counts on admissions for acute heart failure--presentation and outcome--results from a community based registry.

Milo-Cotter O, Felker GM, Uriel N, Kaluski E, Edwards C, Rund MM, Weatherley BD, Cotter G.

Int J Cardiol. 2011 Apr 1;148(1):17-22. doi: 10.1016/j.ijcard.2009.10.009. Epub 2009 Nov 22.

PMID:
19932515
12.

Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.

Cotter G, Metra M, Weatherley BD, Dittrich HC, Massie BM, Ponikowski P, Bloomfield DM, O'Connor CM.

Cardiology. 2010;115(1):29-36. doi: 10.1159/000249280. Epub 2009 Oct 20.

PMID:
19844102
13.

Screening for depression and suicidality in patients with cardiovascular illnesses.

Shemesh E, Annunziato RA, Rubinstein D, Sultan S, Malhotra J, Santra M, Weatherley BD, Feaganes JR, Cotter G, Yehuda R.

Am J Cardiol. 2009 Nov 1;104(9):1194-7. doi: 10.1016/j.amjcard.2009.06.033.

PMID:
19840561
14.

Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome.

Torre-Amione G, Milo-Cotter O, Kaluski E, Perchenet L, Kobrin I, Frey A, Rund MM, Weatherley BD, Cotter G.

J Card Fail. 2009 Oct;15(8):639-44. doi: 10.1016/j.cardfail.2009.04.001. Epub 2009 Jun 13.

PMID:
19786251
15.

Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?

Weatherley BD, Milo-Cotter O, Felker GM, Uriel N, Kaluski E, Vered Z, O'Connor CM, Adams KF, Cotter G.

Fundam Clin Pharmacol. 2009 Oct;23(5):633-9. doi: 10.1111/j.1472-8206.2009.00697.x. Epub 2009 Jul 28.

PMID:
19656213
16.

Rapid clinical assessment of patients with acute heart failure: first blood pressure and oxygen saturation--is that all we need?

Milo-Cotter O, Cotter G, Kaluski E, Rund MM, Felker GM, Adams KF, O'Connor CM, Weatherley BD.

Cardiology. 2009;114(1):75-82. doi: 10.1159/000213051. Epub 2009 Apr 17.

PMID:
19372679
17.

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G.

Lancet. 2009 Apr 25;373(9673):1429-39. doi: 10.1016/S0140-6736(09)60622-X. Epub 2009 Mar 28.

PMID:
19329178
18.

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.

Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM; Protect Steering Committee, Investigators, and Coordinators.

J Card Fail. 2008 Oct;14(8):631-40. doi: 10.1016/j.cardfail.2008.08.010. Epub 2008 Sep 14.

PMID:
18926433
19.

Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia.

Milo-Cotter O, Cotter G, Weatherley BD, Adams KF, Kaluski E, Uriel N, O'Connor CM, Felker GM.

Eur J Heart Fail. 2008 Feb;10(2):196-200. doi: 10.1016/j.ejheart.2008.01.008.

20.

The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987-2001.

Weatherley BD, Nelson JJ, Heiss G, Chambless LE, Sharrett AR, Nieto FJ, Folsom AR, Rosamond WD.

BMC Cardiovasc Disord. 2007 Jan 16;7:3.

21.

Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.

Wattanakit K, Folsom AR, Selvin E, Coresh J, Hirsch AT, Weatherley BD.

J Am Soc Nephrol. 2007 Feb;18(2):629-36. Epub 2007 Jan 10.

22.

Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study.

Wattanakit K, Folsom AR, Duprez DA, Weatherley BD, Hirsch AT.

Atherosclerosis. 2007 Feb;190(2):459-64. Epub 2006 Mar 29.

PMID:
16574125
23.

The reliability of the ankle-brachial index in the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI Family Heart Study (FHS).

Weatherley BD, Chambless LE, Heiss G, Catellier DJ, Ellison CR.

BMC Cardiovasc Disord. 2006 Feb 21;6:7.

24.

Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.

Wattanakit K, Folsom AR, Selvin E, Weatherley BD, Pankow JS, Brancati FL, Hirsch AT.

Atherosclerosis. 2005 Jun;180(2):389-97. Epub 2005 Jan 25.

PMID:
15910867
25.

Have studies of urinary tract infection and preterm delivery used the most appropriate methods?

S O'Neill M, Hertz-Picciotto I, Pastore LM, Weatherley BD.

Paediatr Perinat Epidemiol. 2003 Jul;17(3):226-33.

PMID:
12839532
26.

Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.

Cohen M, Stinnett SS, Weatherley BD, Gurfinkel EP, Fromell GJ, Goodman SG, Fox KA, Califf RM.

Am Heart J. 2000 Jun;139(6):962-70.

PMID:
10827375

Supplemental Content

Loading ...
Support Center